– Firm adds to its team with a new Board Member and two new V.P. hires –

–该公司增加了一名新董事和两名新V。P、 雇佣——

AUSTIN, Texas, Feb. 27, 2024 /PRNewswire/ -- Elevage Medical Technologies ('Elevage'), a portfolio company of Patient Square Capital, dedicated to supporting growth-stage medical device and medical technology companies, today announced key additions to the investment team and board. Vice-Presidents Suchira Sharma and Peter Tortora join the Elevage investment team, along with Dr.

德克萨斯州奥斯汀，2024年2月27日/PRNewswire/-Elevage Medical Technologies（“Elevage”）是Patient Square Capital的一家投资组合公司，致力于支持处于成长阶段的医疗器械和医疗技术公司，今天宣布了投资团队和董事会的关键新增人员。副总裁SuchiraSharma和PeterTortora与Dr。

Josh Makower, a Senior Advisor to Patient Square and Elevage, who will also join the Elevage Board of Directors..

Josh Makower是Patient Square和Elevage的高级顾问，他也将加入Elevage董事会。。

Dr. Evan Melrose, CEO of Elevage Medical, said, 'We are thrilled with these three key additions to the Elevage team. I have known Josh for many years. He is among the industry's most accomplished medical technology inventors and investors. Suchira and Peter are talented and experienced investment professionals who will help identify and execute new partnerships with novel and rapidly growing healthcare businesses and add significant value to our partner companies as we grow and scale them commercially.' .

Elevage Medical首席执行官埃文·梅尔罗斯（EvanMelrose）博士说，“我们对Elevage团队的这三个关键补充感到兴奋。我认识乔希很多年了。他是业内最有成就的医疗技术发明家和投资者之一。苏希拉（Suchira）和彼得（Peter）是一位才华横溢、经验丰富的投资专业人士，他们将帮助确定和执行与新型且快速增长的医疗保健业务的新合作伙伴关系，并在我们商业化发展和规模化的过程中为我们的合作伙伴公司增加重大价值。”。

Dr. Makower is the Yock Family Professor of Medicine and Bioengineering at the Stanford University Schools of Medicine and Engineering and the Co-Founder and Director of the Stanford Byers Center for Biodesign. Dr. Makower is also the Founder & Executive Chairman of ExploraMed, a medical device incubator that has created eleven companies since 1995.

Makower博士是斯坦福大学医学与工程学院Yock家族医学与生物工程教授，也是斯坦福拜尔斯生物设计中心的联合创始人和主任。Makower博士也是ExploraMed的创始人兼执行主席，ExploraMed是一家医疗器械孵化器，自1995年以来创建了11家公司。

Transactions from the ExploraMed portfolio include NeoTract, acquired by Teleflex, Acclarent, acquired by J&J, EndoMatrix, acquired by C.R. Bard, and TransVascular, acquired by Medtronic..

ExploraMed投资组合的交易包括Teleflex收购的NeoTract、J＆J收购的Accularent、C.R.Bard收购的EndoMatrix和美敦力收购的TransVascular。。

Dr. Makower serves on the boards of Revelle Aesthetics, ExploraMed, Moximed, X9, Willow, and Coravin. He holds over 300 patents and patent applications. He received an MBA from Columbia University, an M.D. from the NYU School of Medicine, and a bachelor's degree in Mechanical Engineering from MIT. Additionally, Dr.

Makower博士是Revelle美学、ExploraMed、Moximed、X9、Willow和Coravin的董事会成员。他拥有300多项专利和专利申请。他获得哥伦比亚大学工商管理硕士学位、纽约大学医学院医学博士学位和麻省理工学院机械工程学士学位。此外，博士。

Makower is a Member of the National Academy of Engineering, a Fellow of The National Academy of Inventors and The American Institute for Medical and Biological Engineering, and was awarded the Coulter Award for Healthcare Innovation by the Biomedical Engineering Society in 2018..

Makower是美国国家工程院（National Academy of Engineering）的成员，美国国家发明家学会（National Academy of Inventors）和美国医学与生物工程研究所（American Institute for Medical and Biological Engineering）的研究员，并于2018年被生物医学工程学会（Biomedical Engineering Society）授予库尔特医疗创新奖。。

Ms. Sharma joins Elevage from Revelation Partners, where she invested in commercial-stage companies across all subsectors of healthcare including devices, lab tools, diagnostics, and tech-enabled services. Before Revelation, she was a member of the Life Sciences team at Hercules Capital, where she underwrote structured securities for various clinical-stage companies.

Sharma女士加入了Revolution Partners的Elevate，在那里她投资了医疗保健所有子部门的商业舞台公司，包括设备、实验室工具、诊断和技术支持服务。在被披露之前，她是Hercules Capital生命科学团队的成员，在那里她为各种临床阶段的公司承销结构性证券。

Ms. Sharma holds a B.A. from Northeastern University..

Sharma女士拥有东北大学的学士学位。。

Mr. Tortora was most recently a member of the growth buyout team at Frazier Healthcare Partners, where he was focused on healthcare services and HCIT investments. Before Frazier, he worked for Accelmed Partners, a healthcare technology-focused growth equity firm, and Needham & Company, a healthcare and technology-focused investment bank.

Tortora先生最近是Frazier Healthcare Partners增长收购团队的成员，他专注于医疗服务和HCIT投资。在弗雷泽之前，他曾为专注于医疗保健技术的成长股权公司Accelmed Partners和专注于医疗保健和技术的投资银行Needham&Company工作。

Mr. Tortora received his B.A. from Yale University..

托托拉先生在耶鲁大学获得学士学位。。

About Elevage Medical Technologies

关于Elevage Medical Technologies

Elevage Medical Technologies is a platform created by Patient Square Capital dedicated to supporting medical device and technology companies that can meaningfully improve health outcomes and quality of life for patients. Through capital investment and strategic operational support, Elevage strives to accelerate the pace of innovation in the medical device and technology space.

Elevate Medical Technologies是由Patient Square Capital创建的一个平台，致力于支持医疗设备和技术公司，以有意义地改善患者的健康状况和生活质量。通过资本投资和战略运营支持，Elevate致力于加快医疗器械和技术领域的创新步伐。

To learn more about Elevage, please visit www.elevagemedical.com..

要了解更多有关Elevage的信息，请访问www.elevagemedical.com。。

About Patient Square Capital

关于Patient Square Capital

Patient Square Capital ('Patient Square') is a dedicated health care investment firm with more than $7.5 billion in assets under management as of September 30, 2023. The firm partners with best-in-class management teams whose products, services and technologies improve health. Patient Square utilizes deep industry expertise, a broad network of relationships and a partnership approach to make investments in companies grow and thrive.

Patient Square Capital（“Patient Square”）是一家专门的医疗保健投资公司，截至2023年9月30日，其管理的资产超过75亿美元。该公司与一流的管理团队合作，其产品、服务和技术可改善健康状况。Patient Square利用深厚的行业专业知识、广泛的关系网络和合作方式，使公司的投资得以发展壮大。

Patient Square invests in businesses that strive to improve patient lives, strengthen communities, and create a healthier world. For more information, visit www.patientsquarecapital.com..

Patient Square投资于致力于改善患者生活、加强社区和创造更健康世界的企业。有关更多信息，请访问www.patientsquarecapital.com。。

SOURCE Elevage Medical

源Elevage Medical